GENMAB A/S GMAB

Latest FY: 2025 Healthcare Biotechnology
Market Price $31.91
Market Cap $19.25B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↓-82.7% YoY
$3.72B
3-Yr CAGR: -36.6%
Net Income ↓-86.9% YoY
$1.20B
Net Margin: 32.4%
Free Cash Flow ↓-89.2% YoY
$98.00M
FCF Yield: 0.51%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
20.6%
ROA: 9.4%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (GMAB)

All monetary values in millions ($M)
⚠️ YoY Data Quality Alert
  • FY 2021: Revenue YoY (-16.1%) is identical to Gross Profit YoY (-16.1%). Verify the underlying Revenue and Gross Profit values for FY 2021 and FY 2020.
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016
FY 2017 $2,365.0M $1,344.0M $-3.0M
FY 2018 $3,025.0M +27.9% $1,594.0M $1,612.0M $44.0M
FY 2019 $5,366.0M +77.4% $2,980.0M $2,859.0M +77.4% $111.0M $32.0M
FY 2020 $10,111.0M +88.4% $2,527.8M $5,904.0M +106.5% $170.0M $-137.0M -528.1%
FY 2021 $8,482.0M -16.1% $2,120.5M $3,983.0M -32.5% $208.0M $-44.0M +67.9%
FY 2022 $14,595.0M +72.1% $2,087.7M $7,035.0M +76.6% $283.0M $237.4M +639.5%
FY 2023 $16,474.0M +12.9% $16,248.0M $5,637.0M -19.9% $908.0M $542.0M +128.3%
FY 2024 $21,526.0M +30.7% $2,978.0M $9,164.0M +62.6% $935.0M $908.0M +67.5%
FY 2025 $3,720.0M -82.7% $3,482.0M $1,204.0M -86.9% $135.0M $98.0M -89.2%
$

Valuation

Market Price $31.91
Market Cap $19.25B
Enterprise Value $22.68B
P/E Ratio N/A
P/B Ratio 3.35
FCF Yield 0.51%
Dividend Yield N/A
Shares Outstanding 613,935,890
%

Profitability & Margins

Gross Margin 93.60%
Operating Margin 28.63%
Net Margin 32.37%
Return on Equity (ROE) 20.59%
Return on Assets (ROA) 9.35%
Asset Turnover 0.29x
Revenue 3-Yr CAGR -36.60%
🛡️

Financial Health & Liquidity

Current Ratio 67.09
Cash Ratio 39.88
Debt / Equity 0.881
Debt / Assets 0.400
Cash & Equivalents $1.72B
Total Debt $5.15B
Book Value / Share $9.52
💧

Cash Flow Efficiency

Operating Cash Flow $135.00M
Capital Expenditures (CapEx) $37.00M
Free Cash Flow $98.00M
OCF / Revenue 3.63%
FCF / Revenue 2.63%
FCF 3-Yr CAGR -25.54%
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share $9.52
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2025)

Total Assets $12.87B
Total Liabilities $7.03B
Stockholders' Equity $5.85B
Current Assets $2.88B
Current Liabilities $43.00M